170 related articles for article (PubMed ID: 32723224)
21. Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline.
Thompson IM; Valicenti RK; Albertsen P; Davis BJ; Goldenberg SL; Hahn C; Klein E; Michalski J; Roach M; Sartor O; Wolf JS; Faraday MM
J Urol; 2013 Aug; 190(2):441-9. PubMed ID: 23707439
[TBL] [Abstract][Full Text] [Related]
22. Salvage radiotherapy in prostate cancer patients with biochemical relapse after radical prostatectomy : Prolongation of prostate-specific antigen doubling time in patients with subsequent biochemical progression.
Lohm G; Neumann K; Budach V; Wiegel T; Hoecht S; Gollrad J
Strahlenther Onkol; 2018 Apr; 194(4):325-332. PubMed ID: 29255924
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant versus early Salvage radiation therapy for prostate cancer with adverse pathological features on radical prostatectomy-Do we finally have an answer?
Jain S; Mallick I; Tamhankar AS; Gautam G
Indian J Cancer; 2022; 59(2):170-177. PubMed ID: 35946183
[TBL] [Abstract][Full Text] [Related]
24. Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
Kumar A; Samavedi S; Mouraviev V; Bates AS; Coelho RF; Rocco B; Patel VR
J Robot Surg; 2017 Mar; 11(1):37-45. PubMed ID: 27245233
[TBL] [Abstract][Full Text] [Related]
25. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
26. Oncologic outcomes at 10 years following robotic radical prostatectomy.
Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
[TBL] [Abstract][Full Text] [Related]
27. Does neoadjuvant hormone therapy improve outcome in prostate cancer patients receiving radiotherapy after radical prostatectomy?
Pai HH; Eldridge B; Bishop D; Alexander A; Lesperance M; Blood P; Lim J; Ludgate C
Can J Urol; 2009 Apr; 16(2):4541-52. PubMed ID: 19364426
[TBL] [Abstract][Full Text] [Related]
28. Utilization of Salvage Radiation Therapy for Biochemical Recurrence After Radical Prostatectomy.
Hawken SR; Spratt DE; Qi J; Linsell SM; Cher ML; Ghani KR; Miller DC; Montie JE; Morgan TM;
Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1030-1034. PubMed ID: 30682490
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Perioperative and Early Oncologic Outcomes between Open and Robotic Assisted Laparoscopic Prostatectomy in a Contemporary Population Based Cohort.
Pearce SM; Pariser JJ; Karrison T; Patel SG; Eggener SE
J Urol; 2016 Jul; 196(1):76-81. PubMed ID: 26860793
[TBL] [Abstract][Full Text] [Related]
30. Salvage radiotherapy for biochemical recurrence after radical prostatectomy: does the outcome depend on the prostate cancer characteristics?
Viani GA; Hamamura AC; Correa AC; de Arruda FT
Int Braz J Urol; 2019; 45(2):237-245. PubMed ID: 30676298
[TBL] [Abstract][Full Text] [Related]
31. Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series.
Gandaglia G; Fossati N; Karnes RJ; Boorjian SA; Colicchia M; Bossi A; Seisen T; Cozzarini C; Di Muzio N; Noris Chiorda B; Zaffuto E; Wiegel T; Shariat SF; Goldner G; Joniau S; Battaglia A; Haustermans K; De Meerleer G; Fonteyne V; Ost P; Van Poppel H; Montorsi F; Briganti A
Eur Urol; 2018 Apr; 73(4):512-518. PubMed ID: 29229176
[TBL] [Abstract][Full Text] [Related]
32. Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features.
Hwang WL; Tendulkar RD; Niemierko A; Agrawal S; Stephans KL; Spratt DE; Hearn JW; Koontz BF; Lee WR; Michalski JM; Pisansky TM; Liauw SL; Abramowitz MC; Pollack A; Moghanaki D; Anscher MS; Den RB; Zietman AL; Stephenson AJ; Efstathiou JA
JAMA Oncol; 2018 May; 4(5):e175230. PubMed ID: 29372236
[TBL] [Abstract][Full Text] [Related]
33. Risk stratification of patients with extraprostatic extension and negative lymph nodes at radical prostatectomy: identifying optimal candidates for adjuvant therapy.
Eisenberg MS; Karnes RJ; Kaushik D; Rangel L; Bergstralh EJ; Boorjian SA
J Urol; 2013 Nov; 190(5):1735-41. PubMed ID: 23727312
[TBL] [Abstract][Full Text] [Related]
34. The timing of salvage radiotherapy after radical prostatectomy: a systematic review.
King CR
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):104-11. PubMed ID: 22795730
[TBL] [Abstract][Full Text] [Related]
35. Treatment results of adjuvant radiotherapy and salvage radiotherapy after radical prostatectomy for prostate cancer.
Wadasaki K; Kaneyasu Y; Kenjo M; Matsuura K; Murakami Y; Hashimoto Y; Ito K; Kiriu H; Ito A
Int J Clin Oncol; 2007 Feb; 12(1):37-41. PubMed ID: 17380439
[TBL] [Abstract][Full Text] [Related]
36. Randomised Trial of Adjuvant Radiotherapy Following Radical Prostatectomy Versus Radical Prostatectomy Alone in Prostate Cancer Patients with Positive Margins or Extracapsular Extension.
Hackman G; Taari K; Tammela TL; Matikainen M; Kouri M; Joensuu T; Luukkaala T; Salonen A; Isotalo T; Pétas A; Hendolin N; Boström PJ; Aaltomaa S; Lehtoranta K; Hellström P; Riikonen J; Korpela M; Minn H; Kellokumpu-Lehtinen PL; Pukkala E; Hemminki A;
Eur Urol; 2019 Nov; 76(5):586-595. PubMed ID: 31375279
[TBL] [Abstract][Full Text] [Related]
37. Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control.
Hu JC; Gandaglia G; Karakiewicz PI; Nguyen PL; Trinh QD; Shih YC; Abdollah F; Chamie K; Wright JL; Ganz PA; Sun M
Eur Urol; 2014 Oct; 66(4):666-72. PubMed ID: 24602934
[TBL] [Abstract][Full Text] [Related]
38. Population-based analysis of salvage radical prostatectomy with examination of factors associated with adverse perioperative outcomes.
Pearce SM; Richards KA; Patel SG; Pariser JJ; Eggener SE
Urol Oncol; 2015 Apr; 33(4):163.e1-6. PubMed ID: 25708953
[TBL] [Abstract][Full Text] [Related]
39. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study.
Wiegel T; Lohm G; Bottke D; Höcht S; Miller K; Siegmann A; Schostak M; Neumann K; Hinkelbein W
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1009-16. PubMed ID: 18963539
[TBL] [Abstract][Full Text] [Related]
40. Factors influencing biochemical recurrence in patients who have received salvage radiotherapy after radical prostatectomy: a systematic review and meta-analysis.
Jia ZW; Chang K; Dai B; Kong YY; Wang Y; Qu YY; Zhu YP; Ye DW
Asian J Androl; 2017; 19(4):493-499. PubMed ID: 27241314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]